Hepacivirus

"Hepacivirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.

Descriptor ID	D016174
MeSH Number(s)	B04.450.410 B04.820.250.475
Concept/Terms	Hepacivirus Hepacivirus Hepaciviruses Hepatitis C-Like Viruses Hepatitis C Like Viruses Hepatitis C-Like Virus Hepatitis C virus Hepatitis C virus Hepatitis C viruses

Below are MeSH descriptors whose meaning is more general than "Hepacivirus".

Organisms [B]
Viruses [B04]
Hepatitis Viruses [B04.450]
Hepacivirus [B04.450.410]
RNA Viruses [B04.820]
Flaviviridae [B04.820.250]
Hepacivirus [B04.820.250.475]

Below are MeSH descriptors whose meaning is related to "Hepacivirus".

Below are MeSH descriptors whose meaning is more specific than "Hepacivirus".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepacivirus" by people in this website by year, and whether "Hepacivirus" was a major or minor topic of these publications.

Bar chart showing 117 publications over 27 distinct years, with a maximum of 14 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	2	1	3
1998	1	0	1
2000	1	0	1
2002	1	0	1
2003	1	0	1
2004	2	3	5
2005	1	4	5
2006	2	1	3
2007	3	1	4
2008	3	2	5
2009	3	0	3
2010	2	2	4
2011	11	3	14
2012	6	1	7
2013	8	3	11
2014	9	1	10
2015	2	4	6
2016	2	0	2
2017	5	1	6
2018	0	2	2
2019	1	3	4
2020	2	2	4
2021	2	2	4
2022	1	4	5
2023	1	3	4
2024	0	1	1

Below are the most recent publications written about "Hepacivirus" by people in Profiles.

Sulkowski MS, Martinez A, Tyson GL, Scholz K, Franco RA, Kohli A, Julius SF, Deming P, Fink SA, Lynch K, Roytman M, Stainbrook TR, Turner MD, Viera-Briggs M, Ramers CB. Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs. J Viral Hepat. 2024 06; 31(6):342-356.

View in: PubMed
Boudova S, Tholey D, Fenkel JM, Derman R, Boelig RC. Pregnancy as an Opportunity for Hepatitis C Virus Elimination and Eradication. Am J Trop Med Hyg. 2024 02 07; 110(2):199-201.

View in: PubMed
Kotani K, Enomoto M, Uchida-Kobayashi S, Tamori A, Yukawa-Muto Y, Odagiri N, Motoyama H, Kozuka R, Kawamura E, Hagihara A, Fujii H, Kageyama K, Yamamoto A, Yoshida A, Higashiyama S, Kawabe J, Kawada N. Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis. J Gastroenterol. 2023 04; 58(4):394-404.

View in: PubMed
Beyoglu D, Schwalm S, Semmo N, Huwiler A, Idle JR. Hepatitis C Virus Infection Upregulates Plasma Phosphosphingolipids and Endocannabinoids and Downregulates Lysophosphoinositols. Int J Mol Sci. 2023 01 11; 24(2).

View in: PubMed
Cowan E, Brandspiegel S, Araki B, O'Brien-Lambert C, Merchant R, Buckler DG, Eiting E, Calderon Y. Relationship of hepatitis C risk to hepatitis C test acceptance among adult patients participating in an ED hepatitis C screening programme. Emerg Med J. 2023 May; 40(5):341-346.

View in: PubMed
Azhar A, Tsujita M, Talwar M, Balaraman V, Bhalla A, Eason JD, Nouer SS, Sumida K, Remport A, Hall IE, Griffin R, Rofaiel G, Molnar MZ. CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors. Ren Fail. 2022 Dec; 44(1):831-841.

View in: PubMed
Rivera Rivera J, Fuzzell LN, Garcia J, Rathwell J, Robinson EJ, Chavez M, Fulton H, Whitmer A, Mathew E, Giuliano AR, Vadaparampil ST. Development of a Patient Activation Toolkit for Hepatitis C Virus Testing. J Cancer Educ. 2023 06; 38(3):931-939.

View in: PubMed
Cohen S, Cowan V, Rohan V, Pavlakis M, Curry MP, Adler JT, Safa K, Fleishman A, Shenkel J, Rodrigue JR. Willingness of Kidney and Liver Transplant Candidates to Receive HCV-Infected Organs. J Surg Res. 2022 10; 278:342-349.

View in: PubMed
Heinlein E, Taylor J, Goldberg R, Potts W, RachBeisel J, Medoff D, Li L, Himelhoch S. Impact of a Targeted Intervention on Hepatitis C Care Among African Americans With Serious Mental Illness. Psychiatr Serv. 2022 11 01; 73(11):1278-1281.

View in: PubMed
Force M, Park G, Chalikonda D, Roth C, Cohen M, Halegoua-DeMarzio D, Hann HW. Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level. Viruses. 2022 04 08; 14(4).

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement